A detailed history of Bms Financial Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Bms Financial Advisors, LLC holds 4,068 shares of NVO stock, worth $431,736. This represents 0.44% of its overall portfolio holdings.

Number of Shares
4,068
Previous 5,494 25.96%
Holding current value
$431,736
Previous $874,000 24.71%
% of portfolio
0.44%
Previous 0.61%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

SELL
$155.98 - $172.65 $222,427 - $246,198
-1,426 Reduced 25.96%
4,068 $658,000
Q1 2023

Apr 10, 2023

BUY
$132.34 - $159.14 $14,028 - $16,868
106 Added 1.97%
5,494 $874,000
Q4 2022

Jan 19, 2023

BUY
$102.55 - $135.33 $15,279 - $20,164
149 Added 2.84%
5,388 $0
Q3 2022

Oct 17, 2022

BUY
$95.28 - $116.93 $571 - $701
6 Added 0.11%
5,239 $522,000
Q2 2022

Jul 11, 2022

BUY
$103.24 - $121.81 $540,254 - $637,431
5,233 New
5,233 $583,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bms Financial Advisors, LLC Portfolio

Follow Bms Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bms Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bms Financial Advisors, LLC with notifications on news.